Drug Profile
Research programme: adenosine 1 receptor agonists - Bayer
Latest Information Update: 23 Mar 2010
Price :
$50
*
At a glance
- Originator Bayer
- Class
- Mechanism of Action Adenosine A1 receptor agonists; Purinergic P1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Acute coronary syndromes; Angina pectoris; Atrial fibrillation; Metabolic syndrome